Immunostimulatory adjuvant reverses vaccine response decline in aged models
An immunostimulatory adjuvant effectively reversed reduced antibody production in aged mice and nonhuman primates.
Asset / Drug
Drug and asset intelligence for Immunostimulatory with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
Vaccine Development
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.